Related references
Note: Only part of the references are listed.Lactobacillus rhamnosus GG induces cGAS/STING-dependent type I interferon and improves response to immune checkpoint blockade
Wei Si et al.
GUT (2022)
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer
Shi-Long Zhang et al.
THERANOSTICS (2021)
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
E. Perez-Ruiz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
Yaoyao Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice
Emma Allen-Vercoe et al.
CANCER CELL (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors
Nicholas J. Salgia et al.
EUROPEAN UROLOGY (2020)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow et al.
IMMUNITY (2019)
Exploring the emerging role of the microbiome in cancer immunotherapy
Jessica Fessler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure
Xiaobo Li et al.
ADVANCED SCIENCE (2019)
Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy
Gang Shi et al.
MOLECULAR THERAPY (2019)
Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties
Elsa Jacouton et al.
FRONTIERS IN MICROBIOLOGY (2019)
Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
Yongzhi Yang et al.
THERANOSTICS (2019)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Enterotypes in the landscape of gut microbial community composition
Paul I. Costea et al.
NATURE MICROBIOLOGY (2018)
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
Jinyang Li et al.
IMMUNITY (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Balances: a New Perspective for Microbiome Analysis
J. Rivera-Pinto et al.
MSYSTEMS (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
Claudia Burrello et al.
NATURE COMMUNICATIONS (2018)
Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice
Sunny H. Wong et al.
GASTROENTEROLOGY (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
Jun Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study
James J. Goedert et al.
EBIOMEDICINE (2015)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Ribosomal Database Project: data and tools for high throughput rRNA analysis
James R. Cole et al.
NUCLEIC ACIDS RESEARCH (2014)
Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans
J. Fernandes et al.
NUTRITION & DIABETES (2014)
QUAST: quality assessment tool for genome assemblies
Alexey Gurevich et al.
BIOINFORMATICS (2013)
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Robert C. Edgar
NATURE METHODS (2013)
The gut microbiota - masters of host development and physiology
Felix Sommer et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Lactobacillus brantae sp nov., isolated from faeces of Canada geese (Branta canadensis)
Dmitriy V. Volokhov et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2012)
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss
Joanne M. Bowen et al.
CANCER BIOLOGY & THERAPY (2007)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Share Paper
